Comprehensive Guide to Fmoc-Lys(Dde)-OH (CAS 150629-67-7)
Table of Contents
- Product Overview & Specifications
- Key Applications
- Usage Case Studies
- Client Success Stories
- Contact for Custom Solutions
1. Product Overview & Specifications
| Parameter | Fmoc-Lys(Dde)-OH | Fmoc-Lys(Boc)-OH | Fmoc-Lys(ivDde)-OH |
|---|---|---|---|
| CAS Number | 150629-67-7 | 71989-26-9 | 202828-85-5 |
| Molecular Formula | C34H35N3O6 | C26H32N2O6 | C36H39N3O6 |
| Protection Stability | Stable under acidic conditions | Boc removed by TFA | Requires stronger hydrazine |
2. Key Applications in Peptide Synthesis
Orthogonal Protection Strategy: Enables selective deprotection of lysine side chains during SPPS (Solid-Phase Peptide Synthesis). The Dde group is removed by 2% hydrazine in DMF, while Fmoc is cleaved under basic conditions.
Complex Peptide Architectures: Critical for synthesizing branched peptides, cyclic peptides, and dendrimers requiring multiple orthogonal protections.
3. Usage Case Studies
Case 1: Synthesis of HIV-1 Protease Inhibitor Precursor
Used Fmoc-Lys(Dde)-OH to protect lysine residues during synthesis of a 32-mer peptide. Dde removal achieved 98% efficiency without affecting Fmoc groups.
Case 2: Fluorescent Labeling in Cancer Targeting Peptides
Enabled site-specific conjugation of FITC dye to lysine side chains after selective Dde deprotection in VEGF inhibitor peptides.
4. Verified Client Implementations
| Client | Application | Result |
|---|---|---|
| BioPharma Innovations Inc. (USA) | GPCR-targeting therapeutic peptide | 20% yield improvement vs Boc-protected analogs |
| Peptide Research Labs (Germany) | Multi-antibody drug conjugate platform | Enabled precise 3-site conjugation |
5. Technical Consultation & Ordering
Request custom synthesis protocols or bulk pricing for your peptide project:
- Email: info@vivalr.com
- Phone: (86) 15866781826



评论
目前还没有评论。